Blue Water Vaccines closes $20M IPO; appoints James Sapirstein to board

Onconetix, Inc.

Closed IPO of 2,222,222 shares at $9.00/share; net proceeds ~$17.8M after underwriting costs.
John Rice resigned from board effective Feb 23, 2022; James Sapirstein appointed to board same day.
All outstanding series seed preferred shares converted into 5,626,365 common shares upon closing.
Right of first refusal and co-sale agreement and voting agreement terminated in connection with IPO.
Amended and restated certificate of incorporation and bylaws adopted effective Feb 23, 2022.

item 1.01 item 1.02 item 3.03 item 5.03 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James Sapirstein

member of the Board

ONCO · Onconetix, Inc.

Effective: 2022-02-23
Filed: February 24, 2022, 6:59 PM ET

Effective as of February 23, 2022, the Board appointed James Sapirstein to serve as a member of the Board.

Departed

John Rice

member of the Board of Directors

ONCO · Onconetix, Inc.

Effective: 2022-02-23
Successor: James Sapirstein
Filed: February 24, 2022, 6:59 PM ET

Effective as of February 23, 2022, John Rice resigned as a member of the Board of Directors (the “Board”) of Blue Water Vaccines Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Sapirstein was appointed as member of the Board at Onconetix, Inc..

Action: appointed
Role: member of the Board

Exact text from the filing

Effective as of February 23, 2022, the Board appointed James Sapirstein to serve as a member of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John Rice resigned as member of the Board of Directors at Onconetix, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

Effective as of February 23, 2022, John Rice resigned as a member of the Board of Directors (the “Board”) of Blue Water Vaccines Inc.

View on SEC.gov

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-009250

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.